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Abstract
Putative health effects of dietary trans fatty acids (TFAs) receive a growing attention; while very little is known about the metabolism 
of these special food components. In vitro studies carried out in cultured cells provide an efficient and standardizable approach to 
follow the metabolic fate of TFAs, but it requires suitable techniques for the quantitative measurement of FAs in cell samples. Here, the 
development and validation of a simple and reliable method for the quantification of a group of relevant FAs by gas chromatography 
and flame ionization detection is presented. Sample preparation used a fast one-step and chloroform-free process for simultaneous 
extraction and esterification, and chromatographic separation was achieved in 25 min using a Zebron ZB-88 capillary column. A linear 
calibration (of R2 >0.99) was obtained in the concentration range of 1-200 µg/mL for each FA. Recovery rate was 82 % for samples 
of non-esterified FAs and >95 % for complex lipids, such as ceramides, diglycerides and triglycerides. The LOD and LOQ were below 
0.5 µg/mL, and a robust method precision was achieved (RSD % was below 6 % for each lipid classes). The present method was also 
tested on a cultured cell line with or without FA treatment at close to physiological concentration, and the observed changes in the 
metabolite concentration levels revealed characteristic differences between the metabolism of cis and trans unsaturated FAs.
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1 Introduction
Recently, increasing attention has been focused on the 
health effects of dietary trans fatty acids (TFAs) with 
special emphasis on the role of these food components in 
the development of cardiovascular diseases, cancer and 
diabetes. Living organisms incorporate FAs into a wide 
variety of complex lipids, including phosphoglycerolip-
ids and sphingolipids forming the bilayers in the cellular 
membranes, and also triglycerides for a fuel storage [1]. 
The depot fat is stored in the adipocytes in form of lipid 
droplets and its triglyceride molecules contain endoge-
nously synthetized FAs as well as FAs ingested with nat-
ural or hydrogenated plant oils [2, 3] or animal fat [4]. 
The optimal physical properties of biological membranes 
and fat depots requires a balanced utilization of both sat-
urated and unsaturated FAs [5]. The cellular enzymatic 
systems designed to provide the latter by inserting double 
bonds into the hydrocarbon chains of FAs are stereospe-
cific and invariably yield unsaturated FAs of cis config-
uration. Although the trans isomers cannot be endog-
enous, they are ingested and they appear in the human 
diet from two sources. The TFAs, mostly vaccenate 
(C18:1 trans-Δ11) can be produced by bacteria in ruminant 
animals and taken up by humans with dairy products and 
the meat of these animals [6]. Alternatively, TFAs, mostly 
elaidate (C18:1, trans-Δ9) can be formed as by-products of 
industrial food processing, primarily during hydrogena-
tion of plant oils [7].
Due to some in vivo studies reporting the adverse 
health effect of dietary TFAs [8–11], the maximum trans 
fat content of food products is regulated in many coun-
tries [12, 13]. However, the increasing number of contro-
versial in vivo studies did not unequivocally support the 
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correlation between TFA consumption and human pathol-
ogies [14-16]. It is, therefore, essential to study the metab-
olism and cellular effects of TFAs in vitro in cellular 
experiments at molecular level [17, 18]. 
Gas chromatography is a common method employed 
to analyze the FA composition of different matrices such 
as foods or biological samples. Saponification allows the 
determination of a FA profile that includes both the non-es-
terified molecules and those incorporated in various com-
plex lipids. After alkaline hydrolysis, liberated FAs are 
usually (re)esterified with a low molecular weight alcohol 
in order to yield volatile molecules, and also to avoid the 
formation of hydrogen bonds between the analytes and the 
stationary phase. The sample preparation method devel-
oped by Folch et al. [19] provided an excellent basis for the 
extraction of lipids from biological samples. Extraction 
was carried out using a chloroform/methanol mixture in 
several studies [20–23], and esterification was performed 
with or without a separate saponification step [22–25]. 
Alkaline saponification does not lead to a chemical equi-
librium, thus the conversion is near to 100 %, and the fatty 
acid methyl esters (FAME) along with the non-esterified 
FAs can be easily trans-esterified or esterified in the next, 
acidic reaction [22, 23].
The GC-FID or GC-MS instruments are suitable for the 
chromatographic separation and detection of volatile com-
pounds such as ketone bodies [26], alcohol derivatives [27] 
or FAME species [28, 29]. The chromatographic separation 
of cis and trans (FAME) needs the application of special sta-
tionary phases such as propyl-nitrile-polysiloxane [27, 30].
We aimed to develop and validate a sensitive, reproduc-
ible and precise GC-FID method with a simple and fast 
combined extraction and derivatization process followed 
by an evaporation step, which is suitable for the determina-
tion of saturated and cis- or trans-unsaturated FAs, includ-
ing those incorporated into complex lipids, from cultured 
cells. After validation, the method will be tested by assess-
ing the effects of palmitate, oleate, elaidate or vaccenate 
treatments at close to physiological concentration on the 
FA composition of RINm5F rat insulinoma cells.
2 Materials and methods
2.1 Chemicals and reagents
Supelco 37 Component FAME Mix (Cat. No.: CRM47885), 
trans-vaccenic acid methyl ester (Cat. No.: CRM46905), 
rac-glycerol-1,2-dipalmitate (Cat. No.: SLBN1244V), 
glycerol-trioleate (D2135), methyl-palmitoleate (Cat. No.: 
P9667), sodium hydroxide pellet (S5881), boron trifluoride 
methanol complex solution (61626), sodium chloride 
(S9625) were purchased from Sigma Aldrich, C18:0 
Ceramide was bought from Avanti Polar Lipids, metha-
nol was purchased from Merck, and n-hexane was bought 
from Romil. All experiments and measurements were 
carried out by using Millipore ultrapure water (Milli-Q 
Direct 8 purchased from Merck; 18.2 MΩ.cm at 25 °C).
2.2 Cell cultures
RINm5F rat insulinoma cells were purchased from ATCC 
(CRL-11605) and cultured in RPMI 1640 medium, con-
taining 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 
4.5 g/L glucose, 10 mM HEPES and 1 mM sodium pyru-
vate and supplemented with 10 % fetal bovine serum and 
1 % antibiotics (Thermo Scientific), at 37 °C in humidified 
atmosphere containing 5 % CO2.
2.3 Cell treatment with fatty acids
Treatment of the cells with albumin-conjugated palmitate 
was based on our previous studies [17, 18]. Briefly, palmi-
tate, elaidate, oleate and vaccenate (Sigma) were diluted 
in isopropanol (Molar Chemicals) to a concentration of 
50 mM, conjugated with 4.16 mM fatty-acid-free BSA 
(Sigma) in 1:4 ratio, at 37 °C for 1 h. The working solution 
for FA treatments was always prepared freshly in FBS-free 
and antibiotic-free medium at 50 µM final concentration. 
Control cells were treated only with BSA but without any 
FA. The culture medium had been replaced by FBS-free and 
antibiotic-free medium for 1 h before the cells were treated 
with FAs for 6 h at 70-80 % confluence in 6-well plates.
2.4 Sample preparation – extraction
At 70-80 % confluence, cells were harvested in 100 µL 
of PBS by scrapping, then were centrifuged in a bench-
top centrifuge (5 min, 1500 rpm, 4 °C). The supernatant 
was removed, and cells were suspended in 115 µL PBS. 
Then, 50 µL of each sample was transferred into glass 
crimp vials, 150 µL of methanol with 2 w/v% NaOH solu-
tion was added to each cell suspension, and the samples 
were immediately frozen at 20 °C. Before the analysis, the 
samples were incubated at 90 °C for 30 min. After cool-
ing the samples to room temperature, 400 µL of methanol 
containing 13-15 % boron trifluoride was added, and the 
sample were incubated at 90 °C for 30 min. After cooling, 
200 µL of saturated NaCl solution and 500 µL of n-hex-
ane were added to the solution. FAMEs were extracted 
to the upper phase containing n-hexane. Then, 400 µL of 
the upper phase was transferred to a glass vial and were 
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evaporated to dryness in nitrogen flow. Finally, samples 
were resolved in 200 µL of n-hexane, and were transferred 
to vials for GC analysis.
2.5 Determination of protein concentration
After harvesting the cells, 15 µL of the cell suspensions was 
removed for protein concentration determination. The lysis 
buffer contained 0.1 % SDS, 5 mM EDTA, 150 mM NaCl, 
50 mM Tris, 1 % Tween 20, 1 mM Na3VO4, 1 mM PMSF, 
10 mM benzamidine, 20 mM NaF, 1 mM pNPP and pro-
tease inhibitor cocktail. The lysates were centrifuged with 
benchtop centrifuge (10 min, 10000 rpm, 4 °C). Protein 
concentration of the supernatant was measured with Pierce 
BCA Protein Kit Assay (Thermo Scientific) according to 
the manufacturer’s recommendation.
2.6 Chromatographic separation and detection of fatty 
acids
FAs were separated in a Zebron ZB-88 capillary column 
(60 m × 0.25 mm i.d., 0.20 μm film thickness) by using 
a Shimadzu GC-2014 gas chromatograph equipped with 
a Shimadzu AOC-20s autosampler and a flame ioniza-
tion detector (FID) and a Shimadzu GC Solution. For the 
separation, 1 µL of each sample was injected. The car-
rier gas was hydrogen at 35 cm/s flow rate with a purge 
flow of 3.0 mL/min, and the split-rate was 5. The injec-
tor and detector temperature was set to 250 °C, and the 
oven temperature was increased from 100 °C to 220 °C at 
a ramp of 4 °C/min. For the mass spectrometric detection, 
a Shimadzu GCMS-QP2010 instrument was used.
3 Results
3.1 GC-FID method development
A fast single-step sample preparation method based on 
previously published articles has been applied in the pres-
ent work [26]. The samples were prepared as described in 
Sections 2.4 and 2.5. After the saponification, esterifica-
tion and extraction of lipids, the samples were evaporated 
and resolved in 200 µL of n-hexane. The evaporation and 
the resolution of the samples were needed because without 
this step, a dative bond is formed between the boron tri-
fluoride from the samples and the nitrile-group of the sta-
tionary phase which causes the degradation of the column.
As mentioned before, a Zebron ZB-88 capillary column 
was chosen for the separation of saturated and cis- and 
trans-unsaturated FAMEs. Preliminary measurements with 
the presented sample preparation method were performed 
to get an overall view of the number and type of FAMEs 
in the samples. A Supelco 37 Component FAME Mix was 
used to determine the individual FAMEs in our samples. 
A GC-MS measurement was applied to identify the com-
pounds corresponding each peak in the chromatogram of 
the standard mix. Comparing the two chromatograms, we 
could identify the compound corresponding each peak in 
our samples according to the retention times. However, 
one peak was not found in the FAME MIX, therefore, MS 
detection was used for the identification. According to the 
mass spectra, the compound in question was a monounsat-
urated methyl octadecanoate, but the exact position of the 
double bond could not be determined. Since one of the FAs 
used in the cell treatments was vaccenate, a C18:1, tΔ11 
methyl ester standard was injected. The retention time of 
the analyte and the vaccenate were the same so we assumed 
that the unknown peak derived from vaccenate.
Using this method, chromatographic separation of the 
10 FAMEs could be achieved in 25 min (Fig. 1).
3.2 GC-FID method validation
The specificity was checked by carrying out the sample 
preparation method with solvent samples without cell sus-
pension and by calculating the resolution value between 
the peaks. In our method, there was no peak with the same 
retention time as the analyzed FAMEs.
The resolution values were determined by using GC 
Solution software. Values of the standard solution with the 
largest concentration are shown in Table 1. The values in 
the table refer to the resolution of each peak compared to 
the previous one. As shown, the required 1.5 value was 
not reached in one case, between the elaidate and the vac-
cenate. However, it affects only the calibration but not the 
sample evaluation since there is no elaidate and vaccenate 
in one sample at the same time. Resolution values for the 
peaks in cell samples are presented in Table 2.
For the linearity measurements, we prepared standard 
solutions of FAME standards at eight different concentra-
tions from 1 to 200 µg/mL. Our method was linear in this 
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concentration range with an R2 = 0.998 for each compound. 
In the blank solution, no peak was detected with the reten-
tion time of analytes. To calculate lower limits of detection 
(LOD) and lower limits of quantitation (LOQ), three noise 
peaks were integrated, and from the mean values and the 
calibration curves were calculated. LODs was 0.1 µg/mL for 
each standard and the LOQs were between 0.2-0.5 µg/mL.
Precision of retention time and peak area was investi-
gated by repeated injections (n = 5) of the same, 10 µg/mL 
for each FAME standard solution (Table 3). The relative 
standard deviations were <5 % for the retention times and 
for the peak areas as well. To evaluate the precision of the 
method, three standard solutions from each type of inves-
tigated compound (dipalmitoyl-glycerol for DGs, cis-pal-
mitoleate for non-esterified FAs, stearoyl-sphingosine for 
ceramides and trioleoyl-glycerol for TGs) were prepared 
and injected (Table 4). For all investigated compounds, the 
standard deviation was not more than 6 %.
Fig. 1 Typical chromatograms of FAMEs in cell samples. RINm5F cells were incubated in a medium containing BSA-conjugated elaidate (red line) 
or vaccenate (blue line) at 50 μM. Medium was eliminated, and cell samples were withdrawn after 6 h long incubations. Esterified and non-esterified 
cellular fatty acids were derivatized to methyl esters, and they were separated on a Zebron ZB-88 capillary column with a (propyl-nitrile)-aril-dimethyl-
polysiloxane stationary phase (60 m × 0.25 mm i.d., 0.20 μm film thickness). Ten saturated or cis- or trans-unsaturated FAMEs were detected by 
flame ionization. The presented FAMEs are the following: C16:0 – palmitate, C16:1, tΔ7 – transΔ7 palmitoleate, C16:0 tΔ9 – transΔ9 palmitoleate, 
C16:1, cΔ7 –cisΔ7 palmitoleate, C16:0 cΔ9 – cisΔ9 palmitoleate, C18:0 – stearate, C18:1, tΔ9 – elaidate C18:1, tΔ11 – vaccenate, C18:1, cΔ9 – oleate, 
C18:1, cΔ11 – cis-vaccenate
Table 2 Resolution values for the peaks in cell samples
Compound C16:0 C16:1, tΔ7 C16:1, tΔ9 C16:1, cΔ7 C16:1, cΔ9 C18:0 C18:1, tΔ9 C18:1, tΔ11 C18:1, cΔ9
C18:1, 
cΔ11
C16:0 9.4 10.6 12.7
C16:1, tΔ7 9.4 3.6
C16:1, tΔ9 10.6 2.3
C16:1, cΔ7 12.7 3.6 2.3 2.5
C16:1, cΔ9 2.5 36.2
C18:0 97 36.2 8.6 10.0 12.8
C18:1, tΔ9 8.6 4.0
C18:1, tΔ11 10.0 2.6
C18:1, cΔ9 12.8 4.0 2.6 2.2
C18:1, cΔ11 2.2
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To determine robustness, three parameters of the chro-
matographic method (temperature ramp, flow rate of the car-
rier gas, oven temperature) were changed in two directions 
each. During the ramping of the temperature, 3 and 5 °C/min 
was used instead of 4 °C/min; the flow rate of the carrier gas 
was changed to 34 and 36 cm/s, and the oven temperature 
was set to 98 °C and 102 °C from 100 °C. The determined 
concentrations after the changes are presented in Table 5.
Recovery rate of the sample preparation method was 
determined regarding four types of lipids, methyl-palmi-
toleate for non-esterified FAs, dipalmitoyl-glycerol for 
DGs, stearoyl-sphingosine for ceramides and trioleoyl-glyc-
erol for TGs. For the stock and spiking solutions, standards 
were weighed in 2.00 mL volumetric flasks, and 200 µL of 
chloroform was added to achieve the complete dissolution 
of all lipids, then methanol was used to fill the flask. The 
concentrations of the spiking solutions are shown in Table 6. 
First, 10 µL-10 µL of spiking solution was added to the 
samples containing 50 µL of cell suspension and 150 µL 
of NaOH-methanol mix, or to samples containing 100 µL 
of standard solution and 100 µL of NaOH-methanol mix. 
The sample preparation method was carried out on three 
unspiked cell samples, three spiked cell samples (Table 6) 
and six standard solution sample (Table 7).
3.3 Incorporation of fatty acids into cultured insulinoma 
cells
The FA metabolism is a major determinant of pancreatic 
βcell functions, and also a key stress factor in obesity, 
which can deteriorate insulin secretion. Our optimized 
analytical method was therefore applied to study the 
incorporation of various FAs into RINm5F rat insulinoma 
cells with special emphasis on two TFAs, i.e. elaidate and 
vaccenate, which had not been thoroughly investigated 
in spite of their evident medical importance. Cells were 
treated with BSA-conjugated palmitate, oleate, elaidate 
and vaccenate (50 µM), and alterations in the cellular FA 
profiles were determined in samples prepared after 6 h 
incubation. It was revealed that all of the four FAs added 
to the medium were efficiently internalized by the cells, 
and the treatments caused an obvious elevation of total FA 
contents (Fig. 2). 
Treatment with the saturated C16:0 palmitate resulted in 
a major change of the pattern, as it accumulated remarkably 
(its level doubled to 61 µg/mg protein), and it also led to a 
build-up of C16:1, cΔ9 palmitoleate and C18:0 stearate in the 
cells (by 2 µg/mg protein and by 4 µg/mg protein, respec-
tively). Increase of the concentration of the latter two deriv-
atives is evidently due to intracellular desaturation and elon-
gation processes (Fig. 2). The endogenous cis unsaturated 
C18:1, cΔ9 oleate was also internalized effectively, and its 
concentration increased from 27.57 ± 1.87 (control) to 53.41 ± 
7.65 (oleate-treated) µg/mg protein. There was no alter-
ation in the concentration of C16:1, cΔ7, the intermediate of 
Table 3 Precision of retention times and peak areas
Compound





C16:0 17.767 0.006 30352 3.99
C16:1, cΔ9 18.748 0.007 25357 3.91
C18:0 21.115 0.004 32773 3.83
C18:1, tΔ9 21.666 0.004 23560 3.76
C18:1, tΔ11 21.757 0.005 19832 4.11
C18:1, cΔ9 21.925 0.006 24945 3.79
Table 4 Method precision. Precision of the retention time and the peak 
area was determined by repeated injection of the same standard solution 
for each FAME solution
Compound Concentration [µg/mL] RSD [%]
Diacyl-glycerol C16:0 22.30 0.46
Non-esterified fatty acid C16:1, cΔ9 6.03 1.81
Ceramide C18:0 12.46 3.33
Triacyl-glycerol C18:1, cΔ9 37.23 5.07
Table 5 Measured concentrations in the determination of robustness. Three parameters of the chromatographic separation were changed in two 
directions each, then the concentration of the FAMEs were determined
Compound
RSD [%]
3 °C/min 5 °C/min 34 cm/sec 36 cm/sec 98 °C 102 °C
C16:0 6.17 5.57 5.62 3.60 7.90 2.90
C16:1, cΔ9 6.24 5.63 5.57 3.60 8.16 3.02
C18:0 6.34 5.72 5.73 3.66 7.64 2.88
C18:1, tΔ9 6.45 5.63 5.80 3.62 7.97 3.02
C18:1, tΔ11 6.61 5.83 5.37 3.50 7.22 2.70
C18:1, cΔ9 6.68 5.66 5.47 3.62 7.65 2.71
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oleate degradation after one cycle of β-oxidation; however, 
the concentration of C16:1, cΔ9 palmitoleate, the product of 
palmitate desaturation, decreased from 8.32 ± 1.31 (control) 
to 4.74 ± 1.13 (oleate-treated) µg/mg protein (Fig. 2), which 
indicates a decreased desaturase activity.
Cellular levels of the two investigated TFAs increased 
similarly to that of oleate but they started from zero as 
FAs containing trans double bonds are not endogenous 
in the human and animal organisms (Fig. 2). A marked 
accumulation of the intermediates of elaidate and vacce-
nate βoxidation, C16:1, tΔ7 (2.24 ± 0.58 µg/mg protein; in 
elaidate-treated) and C16:1, tΔ9 (2.76 ± 0.59 µg/mg pro-
tein; in vaccenate-treated), respectively was also seen in 
the appropriate samples (Fig. 2).
4 Discussion
Most of the cells are provided with FAs from the circulatory 
system. Plasma lipoproteins, such as VLDL and chylomicron 
Table 6 Recovery measurements for cell samples. First, 10 µL of spiking solution was added to the samples containing 50 µL of cell suspension and 
150 µL of NaOH-methanol mix, then the sample preparation was carried out, and the concentrations were determined
Compound
Unspiked cells Spiked cells ΔC (α=100%) 
[µg/mL] ΔC [µg/mL] Recovery [%]C [µg/mL] RSD [%] C [µg/mL] RSD [%]
Diacyl-glycerol 16:0 22.30 0.46 28.08 1.88 6.08 5.78 95
Non-esterified fatty acid 16:1, cΔ9 6.03 1.81 20.77 1.88 17.94 14.73 82
Ceramide C18:0 12.46 3.33 15.34 1.69 2.95 2.88 97
Triacyl-glycerol C18:1, cΔ9 37.23 5.07 48.17 0.90 11.45 10.94 96
Table 7 Recovery measurements for standard solutions. First, 10 µL of spiking solution was added to the samples containing 100 µL of standard 
solution and 100 µL of NaOH-methanol mix. then the sample preparation was carried out, and the concentrations were determined
Compound Mass in 100 µL [µg] C100%* [µg/mL] Measured concentration [μg/mL] RSD% Recovery [%]
Diacyl-glycerol 16:0 3.04 12.17 10.91 4.92 90
Non-esterified fatty acid 16:1, cΔ9 8.97 35.52 35.52 2.35 99
Ceramide C18:0 1.48 5.91 5.31 8.32 90
Triacyl-glycerol C18:1, cΔ9 5.73 22.90 21.46 6.09 94
*In case of a 100 % conversion during the esterification step.
Fig 2 Fatty acid profile of the cells. Cells were incubated in a medium containing FA-free BSA (Control) or BSA-conjugated palmitate, oleate, elaidate 
or vaccenate (50 μM) as indicated. Medium was eliminated, and cell samples were withdrawn after 6 h long incubation. The amount of 10 saturated and 
mono-unsaturated FAs was measured by GC-FID after saponification and methylation, and the results were normalized to the total protein content of 
the samples. Data are shown as mean values ± S.D.; n = 9. C16:1, cΔ9 (palmitoleate) is the desaturation product of palmitate, and C18:0 (stearate) is the 
elongation product of palmitate; C16:1, tΔ7 (transΔ7 palmitoleate) is an intermediate of the β-oxidation of elaidate; C16:1, tΔ9 (transΔ9 palmitoleate) 
is an intermediate of the β-oxidation of vaccenate.
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carry liver-derived endogenous and intestine-derived exoge-
nous FAs esterified in triglycerides, respectively. These FAs 
are liberated in the tissue capillaries and taken up as non-es-
terified FAs by the parenchymal cells. In addition, non-es-
terified, so-called free FAs are adsorbed to serum albumin, 
and they are also available for cellular uptake. Pathologies 
associated to high-fat diet and obesity provide overwhelm-
ing evidence that extensive FA supply can severely disturb 
cellular metabolism and signaling, which leads to dysfunc-
tion (lipotoxicity) or even cell death (lipoapoptosis).
It has been also repeatedly demonstrated that saturated 
FAs (e.g. palmitate) cause a greater damage in the cells 
compared to cis unsaturated FAs (e.g. oleate), and this is 
partly due to different efficiency of incorporation of the 
two FA species into complex lipids [17, 18, 31]. There is a 
special group of FAs, however, which is growingly present 
in the diet, and has been shown to have important health 
effects, yet its metabolism in mammalian cells has not been 
properly investigated. This is the group of trans unsatu-
rated FAs, which can derive from meat and dairy products 
of ruminants or from industrially processed vegetable oils. 
Controversial studies have been published on in vivo health 
effects of TFAs [32-34]; and still very little in vitro data are 
available regarding the incorporation of TFAs into com-
plex lipids or their intracellular degradation [17, 18].
In this article, we demonstrate the development of a 
GC-FID method, which is suitable for the separation and 
determination of the metabolites of the major saturated 
and cis or trans unsaturated FAs. The fast sample prepara-
tion method combines the lipid extraction from the sample 
and the lipid methylation into one single step followed by 
the evaporation of the solution which is essential to avoid 
the degradation of the stationary phase. The selected, bio-
logically most relevant FAs, which are saturated FAs and 
positional and configurational isomers of mono-unsatu-
rated FAs, are separated within a 25-min-long chromato-
graphic process. The peaks were identified with a FAME 
Mix standard together with a vaccenate standard solution 
and by mass spectrometric detection. The quantification 
was performed using calibration curves, which were made 
from standard solutions. 
In the validation process we proved that our method 
is specific and robust. The peak resolution values were 
higher than the expected 1.5, except in case of elaidate and 
vaccenate. However, this does not cause any problem in 
the measurements, provided that elaidate and vaccenate 
are not simultaneously present in the samples, as is often 
the case. The lower limit of detection was 0.1 µg/mL for 
all FAMEs while the lower limits of quantitation were 
between 0.2 and 0.5 µg/mL. Regarding the precision and 
accuracy, the standard deviation was below 10 % in all 
cases. Our method is linear in the range between 1-200 µg/
mL. Recoveries for diacyl-glycerols, triacyl-glycerols and 
ceramides were above 95 %; for non-esterified FAs, this 
value was 82 %, which is still adequate for applications 
using biological samples.
Our experiments on FA-treated cells showed the 
expected increase in the concentrations of the FAs 
administered, as well as of some metabolic derivatives. 
The results also indicated some differences between the 
metabolic features of cis and trans FAs. The products of 
elongation and desaturation of palmitate were detected, 
which is a clear sign of an intense metabolism of palmitate 
in the viable cells used in our experiments. Increased con-
centration of trans-palmitoleate (C16:1, tΔ7) and its posi-
tional isomer (C16:1, tΔ9) were found, which are the β-ox-
idation products of elaidate and vaccenate, respectively. 
However, the increase in the concentration of the analo-
gous intermediate of oleate degradation was not observed 
in our experiments. This phenomenon might indicate a 
different affinity of mitochondrial long-chain acyl-CoA 
dehydrogenase (LCAD) enzyme to unsaturated FAs of 
cis or trans configuration. In accordance to our findings, 
Yu et al. demonstrated the difference in the affinity of 
5-trans-tetradecenoyl-CoA and 5-cis-tetradecenoyl-CoA 
to LCAD, which might be responsible for the poor oxi-
dation of elaidate compered to oleate [35]. Since the dif-
ferent efficiency of oxidation likely affects the intensity 
of FA utilization in diverse anabolic pathways, and hence 
the extent of toxicity, the observed phenomenon deserves 
further investigation.
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